ampelopsin has been researched along with Ovarian Neoplasms in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, Y; Ding, F; Li, B; Li, S; Liu, P; Liu, T; Sun, X; Wang, F; Wang, S; Yu, N; Zhang, X; Zhao, Y | 1 |
Chen, X; Luo, Y; Wang, F; Yi, Y; Yuan, D | 1 |
Chan, HF; Chen, M; He, C; Lin, Z; Lu, H; Wang, S; Xu, Y | 1 |
3 other study(ies) available for ampelopsin and Ovarian Neoplasms
Article | Year |
---|---|
Ampelopsin reduces the migration and invasion of ovarian cancer cells via inhibition of epithelial-to-mesenchymal transition.
Topics: Active Transport, Cell Nucleus; Antineoplastic Agents; Cadherins; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Down-Regulation; Epithelial-Mesenchymal Transition; Female; Flavonoids; Humans; I-kappa B Proteins; Neoplasm Metastasis; NF-kappa B; NF-KappaB Inhibitor alpha; Nitriles; Ovarian Neoplasms; Sulfones; Time Factors; Up-Regulation; Vimentin | 2015 |
Golgi reassembly and stacking protein 65 downregulation is required for the anti-cancer effect of dihydromyricetin on human ovarian cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Caspase 3; Cell Line, Tumor; Cell Movement; Down-Regulation; Female; Flavonols; Golgi Matrix Proteins; Humans; MAP Kinase Signaling System; Ovarian Neoplasms; Proto-Oncogene Proteins c-bcl-2; RNA Interference; RNA, Small Interfering; Up-Regulation | 2019 |
Dihydromyricetin Induces Apoptosis and Reverses Drug Resistance in Ovarian Cancer Cells by p53-mediated Downregulation of Survivin.
Topics: Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cell Shape; Down-Regulation; Doxorubicin; Drug Resistance, Neoplasm; Female; Flavonols; Humans; Inhibitor of Apoptosis Proteins; Ovarian Neoplasms; Paclitaxel; S Phase; Signal Transduction; Survivin; Tumor Suppressor Protein p53 | 2017 |